RxDoctor Payments Data

David Hult

Family Medicine · Lincoln, NENPI 1457322281

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 28.1% of the total. Reporting peaked in 2021 at $422 and has fallen 92.9% since, to $30 in 2025.

$1,170in general payments, 2019–2025

Across 76 payments — averaging $15.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$329
  • Amgen$122
  • Novartis$113
  • Novo Nordisk$103
  • Supernus Pharmaceuticals, Inc.$61
  • AstraZeneca$48
  • plus $394 from 17 others

What the payments were for

  • Food & beverage$1,170100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,170 in reported general payments places this provider in the 65th percentile of 981 family medicine providers in Nebraska.

See all family medicine providers in Nebraska →

Other family medicine in Lincoln

See the full list for Nebraska →

Where these figures come from

Is this you, or does something look wrong? →